Cargando…

RF33 | PSUN03 Rates of Pheochromocytoma/Paraganglioma Screening in At-Risk Populations

BACKGROUND: Hypertension is estimated to affect 1: 2 adults in the USA, and secondary hypertension accounts for up to 40% cases. Pheochromocytomas and paragangliomas (PPGL) are thought to be rare causes of hypertension, although their true prevalence might be underestimated. Less than half of patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grigoryan, Seda, Nhan, Winnie, Zhang, Lei, Urban, Caitlin, Holevinski, Lynn, Zhao, Lily, Turcu, Adina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Adrenal
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625061/ http://dx.doi.org/10.1210/jendso/bvac150.291

Ejemplares similares

RF33 | PSUN04 Luteinizing Hormone-Chorionic Gonadotrophin Receptor in Pheochromocytomas
por: Lopez, Antoine-Guy, et al.
Publicado: (2022)

RF33 | PSUN02 Presentation, Management, and Outcomes of Urinary Bladder Paraganglioma: Results from a Multi-center Study
por: Yu, Kai, et al.
Publicado: (2022)

PSUN27 Largest Cohort of Cervical Spine Metastases of Pheochromocytoma/Paraganglioma in the Setting of SDHB Mutation
por: Pacak, Karel, et al.
Publicado: (2022)

PSUN15 Recurrence of Benign Pheochromocytoma
por: Manas, F N U, et al.
Publicado: (2022)

RF21 | PSUN08 Morphologic or Molecular Imaging - Diagnostic Capabilities in von Hippel-Lindau related pheochromocytoma
por: Patel, Mayank, et al.
Publicado: (2022)

Primary Aldosteronism Screening Rates Differ with Sex, Race, and Comorbidities
por: Turcu, Adina F., et al.
Publicado: (2022)

RF19 | PSUN33 Adrenocortical Carcinoma as a Rare Manifestation of Birt-Hogg-Dubé Syndrome
por: Else, Tobias, et al.
Publicado: (2022)

RF09 | PSUN29 Evidence for a Founder Effect of SDHB Exon 1 Complete Deletion in Brazilian Patients with Paraganglioma
por: Fagundes, Gustavo F, et al.
Publicado: (2022)

Mutational Profile of Metastatic Pheochromocytoma and Paraganglioma
por: Choi, Yun Mi, et al.
Publicado: (2021)

RF33 | PSUN01 Clinical Course of Benign Adrenal Cysts: A Single-Center Experience of 90 Patients
por: Young, William F, et al.
Publicado: (2022)

PSUN09 An Unusual Presentation of Pheochromocytoma with Persistent Hypoglycemia, A Case Report
por: Alnahas, Zeinab, et al.
Publicado: (2022)

MON-199 Targeting Pheochromocytoma/Paraganglioma with Polyamine Inhibitors
por: Ghayee, Hans Kumar, et al.
Publicado: (2020)

MON-218 Clinical and Genetic Aspects of Pediatric Pheochromocytomas and Paragangliomas
por: Petenuci, Janaina, et al.
Publicado: (2020)

MON-204 Pheochromocytoma and Paraganglioma: An Emerging Cause of Secondary Osteoporosis
por: Yokomoto-Umakoshi, Maki, et al.
Publicado: (2020)

Novel Germline SUCLG2 Mutations in Patients With Pheochromocytoma and Paraganglioma
por: Vanova, Katerina Hadrava, et al.
Publicado: (2021)

RF09 | PSUN05 Increased Frailty in Patients With Functioning Adrenal Adenomas
por: Dogra, Prerna, et al.
Publicado: (2022)

PSUN11 Outcomes of Nonselective or Selective Alpha-Adrenergic Antagonist for Preoperative Management of Intra-adrenal Pheochromocytoma
por: Heckart, Jonathan, et al.
Publicado: (2022)

ODP032 Case Series: Prazosin in the Preoperative Management of Pheochromocytoma and Paraganglioma
por: Barreiro, Margarita, et al.
Publicado: (2022)

SUN-344 SDHB Immunostaining: Still an Indispensable Tool in Characterising Pheochromocytoma and Paraganglioma
por: Velusamy, Anand, et al.
Publicado: (2019)

MON-377 Hereditary Paraganglioma Pheochromocytoma Syndrome in the Setting of End Stage Renal Disease
por: Harty, Roger
Publicado: (2019)

OR29-4 Pregnancy Outcomes in Women with Pheochromocytoma and Paraganglioma: An International Multi-Center Study
por: Bancos, Irina, et al.
Publicado: (2019)

MON-383 Sporadic Bilateral Pheochromocytoma with Renal Pelvis Paraganglioma: A Rare Coexisting Occurrence
por: Pirela, Daniela, et al.
Publicado: (2019)

OR29-6 Brown Adipose Tissue Activation in SDHx-Related Pheochromocytoma and Paraganglioma: An Ominous Sign?
por: Abdul Sater, Zahraa, et al.
Publicado: (2019)

MON-195 Genetic Analysis and Clinical Characteristics of Hereditary Paraganglioma and Pheochromocytoma Syndrome in Korean Population
por: Choi, Heewon, et al.
Publicado: (2020)

PSUN12 Change of Computed Tomography-Based Body Composition After Adrenalectomy in Patients with Pheochromocytoma: Importance of Sympathetic Activity on Human Fat Metabolism
por: Kim, Beom-Jun, et al.
Publicado: (2022)

RF09 | PSUN06 ARMC5 as a possible regulator of acetylation in the adrenal cortex in partnership with SIRT1
por: Berthon, Annabel, et al.
Publicado: (2022)

MON-385 Malignant Pheochromocytoma/Paraganglioma Syndrome during Pregnancy: Clinical Case Report, a Therapeutic Challenge
por: Sanchez, Pedro, et al.
Publicado: (2019)

MON-214 Biochemical Abnormalities in Endocrine Function Associated with Lutetium 177-DOTATATE Therapy in Metastatic Pheochromocytoma and Paraganglioma
por: Gubbi, Sriram, et al.
Publicado: (2020)

MON-196 A Single-Center Experience of Patients with Metastatic Pheochromocytoma/Paraganglioma Treated with (177)Lu-DOTATATE
por: Roslyakova, Anna, et al.
Publicado: (2020)

Changes in Clinical Presentation and Perioperative Management of Pheochromocytomas and Paragangliomas: A Four-Decade Experience in a Academic Center
por: Uslar, Thomas, et al.
Publicado: (2021)

RF21 | PSUN07 Germline Genetic Testing in a Cohort of Adults with Adrenocortical Carcinoma : Insights From a Clinical Care Setting
por: Mourot, Aurélie, et al.
Publicado: (2022)

RF21 | PSAT77 ROLE OF THE TRANSCRIPTION FACTOR HHEX IN INNER ADRENAL CORTEX HOMEOSTASIS AND RESPONSE TO PROGESTERONE SIGNALING
por: Dumontet, Typhanie, et al.
Publicado: (2022)

PSUN21 Adrenal Incidentaloma: Is Interval Scanning Warranted?
por: Fryer, Antony, et al.
Publicado: (2022)

PSUN13 Transcriptional and epigenetic landscapes of adrenocortical tumors
por: Lerario, Antonio, et al.
Publicado: (2022)

PSUN25 Adrenal Incidentaloma: Is Interval Hormone Testing Warranted?
por: Wachira, Lianne, et al.
Publicado: (2022)

MON-212 Genetic Spectrum Of A Canadian Cohort Of Sporadic Pheochromocytomas And Paragangliomas: Higher Prevalence Of Germline Mutations In PGL And NGS Assay With A Multigene Panel Increases The Mutation Rate
por: Salle, Stefanie Parisien-La, et al.
Publicado: (2020)

Preoperative Amlodipine Is More Efficacious Than Prazosin in Preventing Intraoperative Haemodynamic Instability in Pheochromocytoma/Paraganglioma Patients: Interim Analysis of a Pilot Randomized Controlled Study
por: Memon, Saba Samad, et al.
Publicado: (2021)

PSUN22 Outcomes of Adrenalectomy for Adrenocortical Carcinoma at a Single Institution
por: Gurney, Antonia, et al.
Publicado: (2022)

PSUN24 Adrenal Metastases Treated with Radiotherapy: Development of Adrenal Insufficiency
por: Tumyan, Gayane, et al.
Publicado: (2022)

OR12-5 | LBSAT57 Long-term Follow-Up of Pheochromocytoma/Paraganglioma (PPGL) after first diagnosis: a retrospective single-center study of 173 patients
por: Krall, Christoph, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nvdb66cjf84qlq29qfp22jvg18